Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

MHRA0033320_066 - Application to change to product licence Kryobulin - 12 Dec 1984

Published on: 02 May, 2024

MHRA0033321_097 - Kryobulin Application for Variation of Product Licence - 10 Oct 1975

Published on: 02 May, 2024

MHRA0033321_099 - Kryobulin Application for Proposed Changes - 09 Oct 1975

Published on: 02 May, 2024

MHRA0033335_039 - Recommendation of CMSB regarding licence of Tisseel Kit

Published on: 02 May, 2024

MRCO0000014_004 - Minutes of Blood Transfusion Research Committee Working Party on PostTransfusion Hepatitis meeting - 19 Mar 1971

Published on: 26 April, 2024

MRCO0000032_005 - Letter from Professor Zuckerman to Dr Gibson - 13 Apr 1983

Published on: 26 April, 2024

MRCO0000439_158 - Letter from James Gowans to Sir Henry Yellowlees - 15 Jul 1983

Published on: 26 April, 2024

MRCO0005069 - Minutes of Blood Transfusion Research Committee Working Party on PostTransfusion Hepatitis meeting

Published on: 26 April, 2024

MRCO0005076 - Minutes of Blood Transfusion Research Committee Working Party on PostTransfusion Hepatitis meeting

Published on: 26 April, 2024

MRCO0005276_002 - Minutes of MRC Blood Transfusion Committee meeting - 01 Jul 1978

Published on: 29 April, 2024

MRCO0005276_004 - Membership of the MRC Blood Transfusion Research Committee and its Working Parties

Published on: 29 April, 2024

MULL0001939_058 - Memo from David Castaldi Hyland Division Travenol Laboratories to Distribution - 03 Jun 1981

Published on: 02 May, 2024

MULL0002894 - HemophiliaAssociated AIDS in the United States 1981 to September 1987 - 01 Apr 1988

Published on: 02 May, 2024

MULL0003137 - Clinical Factors Associated With Progression to AIDS in the Italian Cohort of HIVPositive Hemophiliacs - 24 Mar 1994

Published on: 29 April, 2024

MULL0003226 - Briefing on Acquired Immune Deficiency Syndrome AIDS - 12 Oct 1982

Published on: 02 May, 2024

MULL0004337 - Letter from Dr Bruce Evatt to Dr Fred Feldman - 29 Nov 1984

Published on: 02 May, 2024

NHBT0000014_023 - Note of NBTS and Chiron meeting - 19 Oct 1988

Published on: 29 April, 2024

NHBT0000014_041 - AntiHCV Screening with Ortho ELISA Report - 21 Mar 1989

Published on: 29 April, 2024

NHBT0000014_044 - Letter from Professor Cash to Dr Gunson - 31 Mar 1989

Published on: 29 April, 2024

NHBT0000014_097 - Letter from Dr Contreras to Dr Smithies - 01 Dec 1986

Published on: 29 April, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 3591
  • Page 3592
  • Page 3593
  • Page 3594
  • Current page 3595
  • Page 3596
  • Page 3597
  • Page 3598
  • Page 3599
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.